Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
Balkan endemic nephropathy (BEN) presents an unsolved puzzle despite fifty years of its investigation. Academy of Medical Sciences of the Serbian Medical Society organized a round table discussion on current unsolved problems related to BEN. The present paper summarizes presentations, discussion and...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2010-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791004256D.pdf |
id |
doaj-7388c7cdba6f490d95194050af129a42 |
---|---|
record_format |
Article |
spelling |
doaj-7388c7cdba6f490d95194050af129a422021-01-02T05:37:01ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792010-01-011383-425626110.2298/SARH1004256DInvestigation of Balkan endemic nephropathy in Serbia: How to proceed?Đukanović LjubicaStefanović VladisavBasta-Jovanović GordanaBukvić DanicaGlogovac StevanDimitrijević JovanĐurić SunčicaJanković SlavenkaLukić LjiljanaMarić IvkoNikolić JovanNovaković IvanaPejović VesnaRadisavljević SnežanaRakićBalkan endemic nephropathy (BEN) presents an unsolved puzzle despite fifty years of its investigation. Academy of Medical Sciences of the Serbian Medical Society organized a round table discussion on current unsolved problems related to BEN. The present paper summarizes presentations, discussion and conclusions of this meeting. During the last fifty years, the course of BEN prolonged and it shifted towards the older age in all endemic foci. Data on the incidence of BEN have been controversial and frequently based on the data on the number of BEN patients starting haemodialysis treatment. In Serbia, BEN patients present 6.5% of haemodialysis population and this percentage differs among different centres ranging from 5% (Leskovac) to 46% (Lazarevac). Maintenance of high prevalence of BEN patients on regular haemodialysis indicates that BEN is not an expiring disease. In addition, recent data have shown more frequent microalbuminuria and low-molecular weight proteinuria in children from endemic than from nonendemic families. Aetiology of BEN is still unknown despite numerous investigations of environmental and genetic factors. Today, there is a very current hypothesis on the aetiological role of aristolochic acid but the role of viruses, geochemical factors and genetic factors must not be neglected. Morphological features of BEN are nonspecific and characterized by acellular interstitial fibrosis, tubular atrophy and changes on preand postglomerular vessels. New immunohistochemical and molecular biology methods offer a new approach to BEN investigation. Association of BEN with high incidence of upperurothelial tumours is well-known. Recent studies have shown significant changes of demographic characteristics of patients suffering upper-urothelial tumours, their prevalence in different endemic foci and characteristics of tumours. Further studies of BEN should be directed to determination of incidence and prevalence of disease in different endemic foci, investigations of different insufficiently examined aetiological factors as well as pathomorphological features of the disease by the use of modern methods. http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791004256D.pdfBalkan endemic nephropathyepidemiologyAetiology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Đukanović Ljubica Stefanović Vladisav Basta-Jovanović Gordana Bukvić Danica Glogovac Stevan Dimitrijević Jovan Đurić Sunčica Janković Slavenka Lukić Ljiljana Marić Ivko Nikolić Jovan Novaković Ivana Pejović Vesna Radisavljević Snežana Rakić |
spellingShingle |
Đukanović Ljubica Stefanović Vladisav Basta-Jovanović Gordana Bukvić Danica Glogovac Stevan Dimitrijević Jovan Đurić Sunčica Janković Slavenka Lukić Ljiljana Marić Ivko Nikolić Jovan Novaković Ivana Pejović Vesna Radisavljević Snežana Rakić Investigation of Balkan endemic nephropathy in Serbia: How to proceed? Srpski Arhiv za Celokupno Lekarstvo Balkan endemic nephropathy epidemiology Aetiology |
author_facet |
Đukanović Ljubica Stefanović Vladisav Basta-Jovanović Gordana Bukvić Danica Glogovac Stevan Dimitrijević Jovan Đurić Sunčica Janković Slavenka Lukić Ljiljana Marić Ivko Nikolić Jovan Novaković Ivana Pejović Vesna Radisavljević Snežana Rakić |
author_sort |
Đukanović Ljubica |
title |
Investigation of Balkan endemic nephropathy in Serbia: How to proceed? |
title_short |
Investigation of Balkan endemic nephropathy in Serbia: How to proceed? |
title_full |
Investigation of Balkan endemic nephropathy in Serbia: How to proceed? |
title_fullStr |
Investigation of Balkan endemic nephropathy in Serbia: How to proceed? |
title_full_unstemmed |
Investigation of Balkan endemic nephropathy in Serbia: How to proceed? |
title_sort |
investigation of balkan endemic nephropathy in serbia: how to proceed? |
publisher |
Serbian Medical Society |
series |
Srpski Arhiv za Celokupno Lekarstvo |
issn |
0370-8179 |
publishDate |
2010-01-01 |
description |
Balkan endemic nephropathy (BEN) presents an unsolved puzzle despite fifty years of its investigation. Academy of Medical Sciences of the Serbian Medical Society organized a round table discussion on current unsolved problems related to BEN. The present paper summarizes presentations, discussion and conclusions of this meeting. During the last fifty years, the course of BEN prolonged and it shifted towards the older age in all endemic foci. Data on the incidence of BEN have been controversial and frequently based on the data on the number of BEN patients starting haemodialysis treatment. In Serbia, BEN patients present 6.5% of haemodialysis population and this percentage differs among different centres ranging from 5% (Leskovac) to 46% (Lazarevac). Maintenance of high prevalence of BEN patients on regular haemodialysis indicates that BEN is not an expiring disease. In addition, recent data have shown more frequent microalbuminuria and low-molecular weight proteinuria in children from endemic than from nonendemic families. Aetiology of BEN is still unknown despite numerous investigations of environmental and genetic factors. Today, there is a very current hypothesis on the aetiological role of aristolochic acid but the role of viruses, geochemical factors and genetic factors must not be neglected. Morphological features of BEN are nonspecific and characterized by acellular interstitial fibrosis, tubular atrophy and changes on preand postglomerular vessels. New immunohistochemical and molecular biology methods offer a new approach to BEN investigation. Association of BEN with high incidence of upperurothelial tumours is well-known. Recent studies have shown significant changes of demographic characteristics of patients suffering upper-urothelial tumours, their prevalence in different endemic foci and characteristics of tumours. Further studies of BEN should be directed to determination of incidence and prevalence of disease in different endemic foci, investigations of different insufficiently examined aetiological factors as well as pathomorphological features of the disease by the use of modern methods. |
topic |
Balkan endemic nephropathy epidemiology Aetiology |
url |
http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791004256D.pdf |
work_keys_str_mv |
AT đukanovicljubica investigationofbalkanendemicnephropathyinserbiahowtoproceed AT stefanovicvladisav investigationofbalkanendemicnephropathyinserbiahowtoproceed AT bastajovanovicgordana investigationofbalkanendemicnephropathyinserbiahowtoproceed AT bukvicdanica investigationofbalkanendemicnephropathyinserbiahowtoproceed AT glogovacstevan investigationofbalkanendemicnephropathyinserbiahowtoproceed AT dimitrijevicjovan investigationofbalkanendemicnephropathyinserbiahowtoproceed AT đuricsuncica investigationofbalkanendemicnephropathyinserbiahowtoproceed AT jankovicslavenka investigationofbalkanendemicnephropathyinserbiahowtoproceed AT lukicljiljana investigationofbalkanendemicnephropathyinserbiahowtoproceed AT maricivko investigationofbalkanendemicnephropathyinserbiahowtoproceed AT nikolicjovan investigationofbalkanendemicnephropathyinserbiahowtoproceed AT novakovicivana investigationofbalkanendemicnephropathyinserbiahowtoproceed AT pejovicvesna investigationofbalkanendemicnephropathyinserbiahowtoproceed AT radisavljevicsnezana investigationofbalkanendemicnephropathyinserbiahowtoproceed AT rakic investigationofbalkanendemicnephropathyinserbiahowtoproceed |
_version_ |
1724358766779957248 |